Muscle cramps associated with vincristine therapy

Area of Science:

• Neurology
• Oncology
• Pharmacology

Background:

• Vincristine is a common chemotherapy agent.
• Vincristine can cause peripheral neuropathy, a significant side effect.
• Muscle cramps are a reported, but not fully understood, symptom of vincristine neurotoxicity.

Purpose of the Study:

• To evaluate the clinical course of vincristine-induced neuropathy presenting as muscle cramps.
• To determine the relationship between muscle cramps and the severity of vincristine neurotoxicity.
• To assess the impact of vincristine withdrawal on cramp symptoms.

Main Methods:

• Retrospective evaluation of 14 patients experiencing muscle cramps during vincristine chemotherapy.
• Assessment of cramp onset, duration, and affected extremities.
• Clinical examination for signs of peripheral neuropathy and other neurotoxic manifestations.

Main Results:

• Muscle cramps appeared between 3 days and 4 months after starting vincristine (median cumulative dose 3.1 mg/m2).
• Cramps affected lower and upper extremities in most patients and persisted for months.
• Peripheral neuropathy signs were present in all patients, with cramps being the initial symptom in some.

Conclusions:

• Vincristine-induced muscle cramps are a common manifestation of neurotoxicity.
• Muscle cramps alone do not necessarily indicate severe neurotoxicity.
• Symptomatic improvement often occurs after vincristine withdrawal, suggesting cramps may not warrant automatic therapy interruption.